Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the gap between innovation and capital

RA Capital Investor Connect
Online

RA Capital

Focus on Biotech Therapeutic Companies

Program

RA Capital is a multi-stage investment manager focused on company creation and evidence-based investing across the healthcare and life sciences sectors. The firm invests in companies developing therapeutics, medical devices, diagnostics, research tools, and life science-enabling technologies. RA Capital’s global portfolio includes both private and public companies and spans nearly all therapeutic areas and stages, from discovery through commercialization.

Event

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with RA Capital.

RA Capital  primarily targets therapeutics companies raising Seed through Series B rounds. Companies that already have, or are expected to secure a Development Candidate as part of the current financing are typically the strongest fit. While the firm invests across various stages, it favors companies with de-risked assets, proximity to the clinic, and a clear path to meaningful milestones. Ideally, companies should be positioned to achieve clinical proof-of-concept with the current or subsequent funding round. RA Capital partners with teams advancing high-impact science to build transformative, long-lasting biotech companies.


Applications will be selected based on meeting the following criteria:

Geography

Open to investments globally.

 

Company type

Seed to Series B, with preference for later stage, derisked companies.

 

Modalities of Interest

  • Biologics
  • Biosimilars
  • Cell therapies
  • CRISPR-based therapies
  • Gene therapies
  • Microbiome-based therapies
  • Protein-based therapies
  • Regenerative Medicine
  • RNA-based therapeutics
  • Small molecule
  • Vaccines

 

Stage

Companies seeking funding for Pre-Seed, Seed, Series A and Series B.

 


Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.